A seguir

Reprodução automática

Jonathan Trent on Trabectedin for Soft Tissue Sarcoma

2 Visualizações • 07/18/23
Compartilhar
Embutir
administrator
administrator
Assinantes
0

Jonathan Trent, MD, PhD, associate director for clinical research, director of the Sarcoma Medical Research Program at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, discusses the approval of trabectedin (Yondelis) to treat patients with soft tissue sarcoma.

Mostre mais
0 Comentários sort Ordenar por
Comentários do Facebook

A seguir

Reprodução automática